Discontinuation report LOTENSIN 5MG
| Report ID | 15053 |
| Drug Identification Number | 00885835 |
| Brand name | LOTENSIN 5MG |
| Common or Proper name | LOTENSIN 5MG |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BENAZEPRIL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 2 X 14 |
| ATC code | C09AA |
| ATC description | ACE INHIBITORS, PLAIN |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-07-10 |
| Actual discontinuation date | 2017-07-31 |
| Remaining supply date | 2017-12-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Inventory depleted |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-09-26 | French | Compare |
| v4 | 2017-09-26 | English | Compare |
| v3 | 2017-07-11 | English | Compare |
| v2 | 2017-07-10 | French | Compare |
| v1 | 2017-07-10 | English | Compare |
Showing 1 to 5 of 5